Aesthetic Surgery Procedures Market Size, Share, Report 2023-2032
The global aesthetic surgery procedures market size was estimated at around USD 50.75 billion in 2022 and it is projected to hit around USD 171.36 billion by 2032, growing at a CAGR of 12.94% from 2023 to 2032. The aesthetic surgery procedures market in the United States was accounted for USD 17.2 billion in 2022.
Key Pointers
Report Scope of the Aesthetic Surgery Procedures Market
| Report Coverage | Details |
| Revenue Share of North America in 2022 | 36% |
| Revenue Forecast by 2032 | USD 171.36 billion |
| Growth Rate from 2023 to 2032 | CAGR of 12.94% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Companies Covered | Long Island Plastic Surgical Group; Westlake Dermatology; Piedmont Plastic Surgery & Dermatology; SKINovative of Gilbert-Medical Spa; Toronto Cosmetic Clinic (TCC); Laser Clinic United Kingdom; VIVA Skin Clinic; Therapie Clinic; Nova Aesthetic Clinic; Renovo Skin Clinic; SILK Laser Clinics; Laser Clinic Australia |
The market has experienced significant growth in recent years due to several factors, including increasing consumer demand for cosmetic enhancements, advancements in surgical techniques and technology, and a growing acceptance of aesthetic procedures in society. The market includes a wide range of surgical procedures targeting various areas of the body, such as breast augmentation/reduction, liposuction, eyelid surgery, abdominoplasty, and rhinoplasty. The market has witnessed tremendous growth as the number of experienced professionals and success rate for surgical procedures have increased.
Factors, such as high disposable income and willingness to undergo aesthetic treatments, are boosting market growth. Moreover, minimally invasive procedures have gained popularity due to their numerous benefits, including reduced scarring, shorter recovery times, and decreased risk of complications. Non-surgical options, such as injectables (e.g., Botox, dermal fillers), laser treatments, and non-invasive body contouring procedures have expanded the options available to patients, attracting those who prefer less invasive approaches. For instance, according to the Aesthetic Society (U.S.), non-invasive body fat reduction was among the top 5 non-invasive procedures in the U.S. in 2020 with 140,314 procedures performed.
Furthermore, aesthetic surgery procedures are often elective and typically not covered by insurance. As disposable incomes increase globally, more people can afford these procedures. Thus, growing disposable income has expanded the potential customer base for aesthetic surgery procedures. Adding to it, the proliferation of social media platforms has significantly impacted the market. The constant exposure to images of celebrities, influencers, and peers showcasing their cosmetic enhancements has increased awareness and acceptance of aesthetic procedures. People increasingly seek to emulate the idealized beauty standards they encounter on social media. The COVID-19 pandemic had significantly affected the aesthetic medicine market.
Initially, social distancing and a sudden sharp cut in consumers' income levels had negatively impacted the aesthetic medicine market. The market had witnessed a phase of short-term negative growth owing to factors, such as a decline in service demand, limited operations, temporary closures of beauty centers, and disruption in the manufacturing & supply chain. However, remote working has increased the time spent on Zoom calls. People are paying attention to their physical appearance closely. This has increased the demand for cosmetic surgeries, with Botox being one of the most preferred procedures. Interest in non-invasive procedures has increased during the past few months while interest in invasive procedures has declined.
Procedure Type Insights
On the basis of procedure type, the market has been segmented into breast, face & head, and body & extremities. The body and extremities segment dominated the market with the highest share of 51% in 2022. The segment will expand further at a lucrative CAGR from 2023 to 2032 on account of the growing emphasis on body contouring and sculpting, driven by societal beauty standards and the desire for a more proportionate and aesthetically pleasing physique. Furthermore, the increasing focus on physical fitness and the influence of social media platforms showcasing idealized body shapes have fueled the demand for procedures that enhance body aesthetics.
On the other hand, the face & head segment is expected to register the fastest growth rate during the forecast period. This growth can be attributed to the high demand for facial rejuvenation, an aging population seeking to address signs of aging, cultural & societal influences that emphasize facial aesthetics, the popularity of non-invasive & minimally invasive procedures, psychological & emotional impact of enhancing facial features, and advancements in surgical techniques & technology.
End-use Insights
On the basis of end-uses, the market has been segmented into cosmetic surgery clinics and hospitals. The cosmetic surgery clinics segment dominated the market in 2022 and accounted for the largest share of over 62% of the overall revenue due to their specialization in various aesthetic procedures, including those related to body contouring and breast surgery. Surgeons in these centers often have extensive experience and expertise in performing aesthetic surgery procedures, ensuring optimal outcomes and patient satisfaction. Moreover, cosmetic surgery clinics are more focused on aesthetic outcomes as they understand the impact of aesthetic surgery procedures on a patient's self-confidence and body image and strive to provide a natural look, balanced results, thereby contributing to the demand for cosmetic surgery centers.
On the other hand, the hospitals segment is anticipated to register a lucrative growth rate during the forecast period. Hospitals provide comprehensive healthcare facilities, including specialized departments and equipment for various medical conditions. With the growing recognition of aesthetic surgery procedures as a medical concern, hospitals have expanded their services to include these treatment options, ensuring that patients can access specialized care in a hospital setting.
Regional Insights
North America held the largest revenue share of over 36% in 2022 on account of the advanced healthcare infrastructure, stringent regulatory environment, emphasis on patient safety & quality of care, and the presence of key market players in this region. Moreover, the greater affordability of healthcare services and relatively higher disposable income levels enable individuals to pursue aesthetic surgery treatments more readily. Furthermore, the regional market of North America is highly competitive, with the presence of various specialized clinics, hospitals, and healthcare providers offering a wide range of treatment options.
This competition drives innovation and ensures a high standard of care, further solidifying the region's dominance in the global market. Asia Pacific is expected to register the fastest growth rate during the forecast period. The awareness about aesthetic surgery and its treatment options is increasing in the Asia Pacific region, therefore the stigma associated with aesthetic surgery procedures is gradually diminishing, leading to greater acceptance and a higher demand for treatments. Moreover, Asia Pacific has witnessed significant economic growth in recent years, resulting in an increase in disposable income levels, further boosting the market growth in the region.
Aesthetic Surgery Procedures Market Segmentations:
By Procedure Type
By End-use
By Regional
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Aesthetic Surgery Procedures Market
5.1. COVID-19 Landscape: Aesthetic Surgery Procedures Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Aesthetic Surgery Procedures Market, By Procedure Type
8.1. Aesthetic Surgery Procedures Market, by Procedure Type, 2023-2032
8.1.1. Breast
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Face & Head
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Body & Extremities
8.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Aesthetic Surgery Procedures Market, By End-use
9.1. Aesthetic Surgery Procedures Market, by End-use, 2023-2032
9.1.1. Cosmetic Surgery Clinics
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Hospitals
9.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Aesthetic Surgery Procedures Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Procedure Type (2020-2032)
10.1.2. Market Revenue and Forecast, by End-use (2020-2032)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Procedure Type (2020-2032)
10.1.3.2. Market Revenue and Forecast, by End-use (2020-2032)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Procedure Type (2020-2032)
10.1.4.2. Market Revenue and Forecast, by End-use (2020-2032)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Procedure Type (2020-2032)
10.2.2. Market Revenue and Forecast, by End-use (2020-2032)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Procedure Type (2020-2032)
10.2.3.2. Market Revenue and Forecast, by End-use (2020-2032)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Procedure Type (2020-2032)
10.2.4.2. Market Revenue and Forecast, by End-use (2020-2032)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Procedure Type (2020-2032)
10.2.5.2. Market Revenue and Forecast, by End-use (2020-2032)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Procedure Type (2020-2032)
10.2.6.2. Market Revenue and Forecast, by End-use (2020-2032)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Procedure Type (2020-2032)
10.3.2. Market Revenue and Forecast, by End-use (2020-2032)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Procedure Type (2020-2032)
10.3.3.2. Market Revenue and Forecast, by End-use (2020-2032)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Procedure Type (2020-2032)
10.3.4.2. Market Revenue and Forecast, by End-use (2020-2032)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Procedure Type (2020-2032)
10.3.5.2. Market Revenue and Forecast, by End-use (2020-2032)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Procedure Type (2020-2032)
10.3.6.2. Market Revenue and Forecast, by End-use (2020-2032)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Procedure Type (2020-2032)
10.4.2. Market Revenue and Forecast, by End-use (2020-2032)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Procedure Type (2020-2032)
10.4.3.2. Market Revenue and Forecast, by End-use (2020-2032)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Procedure Type (2020-2032)
10.4.4.2. Market Revenue and Forecast, by End-use (2020-2032)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Procedure Type (2020-2032)
10.4.5.2. Market Revenue and Forecast, by End-use (2020-2032)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Procedure Type (2020-2032)
10.4.6.2. Market Revenue and Forecast, by End-use (2020-2032)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Procedure Type (2020-2032)
10.5.2. Market Revenue and Forecast, by End-use (2020-2032)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Procedure Type (2020-2032)
10.5.3.2. Market Revenue and Forecast, by End-use (2020-2032)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Procedure Type (2020-2032)
10.5.4.2. Market Revenue and Forecast, by End-use (2020-2032)
Chapter 11. Company Profiles
11.1. Long Island Plastic Surgical Group
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Westlake Dermatology
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Piedmont Plastic Surgery & Dermatology
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. SKINovative of Gilbert-Medical Spa
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. LTE Scientific
11.5. Toronto Cosmetic Clinic (TCC)
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Laser Clinic United Kingdom
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. VIVA Skin Clinic
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Therapie Clini
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Nova Aesthetic Clinic
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Renovo Skin Clinic
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers